A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma is a research paper published in Cancer Discovery (2022). On theSindex it has a DataRank of 0.529. It has been cited 33 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.529
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Cancer Institute
Grant: 5P30CA008748-56
Cancer Center Support Grant
U.S. Department of Defense
Grant: KC180165
Open Medicine Foundation
Grant: CA233944
German Research Foundation
Grant: EXC 2180 - 390900677
National Cancer Institute
Grant: 5R01CA258886
Moffitt Cancer Center
Grant: P30-CA076292
NCI NIH HHS
Grant: P30 CA008748
NCI NIH HHS
Grant: P30 CA076292
NIH HHS
Grant: S10 OD023669
NCI NIH HHS
Grant: R01 CA233944
NCI NIH HHS
Grant: R01 CA258886
Deutsche Forschungsgemeinschaft
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5R01CA258886-03
Macrophages as modulators of T cell function and therapeutic response in clear cell renal cell carcinoma
National Institutes of Health
Grant: 3P30CA076292-24S2
Moffitt Cancer Center Support Grant
Shulamit Katzman Endowed Postdoctoral Research Fellowship
Cycle for Survival
Weiss Family Fund
FWCI
3.95
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals